SU‐E‐T‐66

IMRT Dose Reconstruction Using An A‐Si EPID‐Based System

M. Fitzpatrick, L. Vazquez‐quino, H. Alkhatib, X. Chen, C. Shi, Nikos Papanikolaou

Research output: Contribution to journalArticle

Abstract

Purpose: This study examines the feasibility of patient dosimetric verification of intensity modulated radiotherapy (IMRT) treatment plans using an amorphous silicon (a‐Si) electronic portal imaging device (EPID). Methods: Patient specific IMRT treatment plans are created and exported to a linear accelerator for dosimetric verification. An a‐Si EPID device mounted on the accelerator is positioned at 110 cm SDD and configured to operate in integrated image acquisition mode. Planar EPID images transverse to the beam direction are acquired for each treatment angle of an IMRT plan by direct irradiation of an a‐Si EPID. Using software developed in‐house these images are then transformed into fluence distributions for importation into a commercial treatment planning system. After import, the fluence distributions are then used to calculate dose distributions and compared with planned dose distributions. Results: Planar dose profile gamma analysis (3%, 3 mm) of two 6 MV prostate IMRT plans displays a 99% passing rate. Isocenter point of interest (POI) dose comparisons for 2 liver, 1 abdomen and 2 prostate treatment plans range between 2.8–4.2% Conclusions: IMRT dosimetric verification of planar dose profiles using an a‐Si EPID is feasible. POI dose comparisons indicate that our model might benefit by further refinements. Research sponsored by a grant from Oncology Data Systems, Inc, Oklahoma City, OK.

Original languageEnglish (US)
Pages (from-to)3500
Number of pages1
JournalMedical Physics
Volume38
Issue number6
DOIs
StatePublished - 2011

Fingerprint

Intensity-Modulated Radiotherapy
Silicon
Equipment and Supplies
Prostate
Therapeutics
Particle Accelerators
Organized Financing
Feasibility Studies
Information Systems
Abdomen
Software
Liver
Research

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐E‐T‐66 : IMRT Dose Reconstruction Using An A‐Si EPID‐Based System. / Fitzpatrick, M.; Vazquez‐quino, L.; Alkhatib, H.; Chen, X.; Shi, C.; Papanikolaou, Nikos.

In: Medical Physics, Vol. 38, No. 6, 2011, p. 3500.

Research output: Contribution to journalArticle

Fitzpatrick, M, Vazquez‐quino, L, Alkhatib, H, Chen, X, Shi, C & Papanikolaou, N 2011, 'SU‐E‐T‐66: IMRT Dose Reconstruction Using An A‐Si EPID‐Based System', Medical Physics, vol. 38, no. 6, pp. 3500. https://doi.org/10.1118/1.3612017
Fitzpatrick, M. ; Vazquez‐quino, L. ; Alkhatib, H. ; Chen, X. ; Shi, C. ; Papanikolaou, Nikos. / SU‐E‐T‐66 : IMRT Dose Reconstruction Using An A‐Si EPID‐Based System. In: Medical Physics. 2011 ; Vol. 38, No. 6. pp. 3500.
@article{3292db89b2f14167abb629678d0a1579,
title = "SU‐E‐T‐66: IMRT Dose Reconstruction Using An A‐Si EPID‐Based System",
abstract = "Purpose: This study examines the feasibility of patient dosimetric verification of intensity modulated radiotherapy (IMRT) treatment plans using an amorphous silicon (a‐Si) electronic portal imaging device (EPID). Methods: Patient specific IMRT treatment plans are created and exported to a linear accelerator for dosimetric verification. An a‐Si EPID device mounted on the accelerator is positioned at 110 cm SDD and configured to operate in integrated image acquisition mode. Planar EPID images transverse to the beam direction are acquired for each treatment angle of an IMRT plan by direct irradiation of an a‐Si EPID. Using software developed in‐house these images are then transformed into fluence distributions for importation into a commercial treatment planning system. After import, the fluence distributions are then used to calculate dose distributions and compared with planned dose distributions. Results: Planar dose profile gamma analysis (3{\%}, 3 mm) of two 6 MV prostate IMRT plans displays a 99{\%} passing rate. Isocenter point of interest (POI) dose comparisons for 2 liver, 1 abdomen and 2 prostate treatment plans range between 2.8–4.2{\%} Conclusions: IMRT dosimetric verification of planar dose profiles using an a‐Si EPID is feasible. POI dose comparisons indicate that our model might benefit by further refinements. Research sponsored by a grant from Oncology Data Systems, Inc, Oklahoma City, OK.",
author = "M. Fitzpatrick and L. Vazquez‐quino and H. Alkhatib and X. Chen and C. Shi and Nikos Papanikolaou",
year = "2011",
doi = "10.1118/1.3612017",
language = "English (US)",
volume = "38",
pages = "3500",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐66

T2 - IMRT Dose Reconstruction Using An A‐Si EPID‐Based System

AU - Fitzpatrick, M.

AU - Vazquez‐quino, L.

AU - Alkhatib, H.

AU - Chen, X.

AU - Shi, C.

AU - Papanikolaou, Nikos

PY - 2011

Y1 - 2011

N2 - Purpose: This study examines the feasibility of patient dosimetric verification of intensity modulated radiotherapy (IMRT) treatment plans using an amorphous silicon (a‐Si) electronic portal imaging device (EPID). Methods: Patient specific IMRT treatment plans are created and exported to a linear accelerator for dosimetric verification. An a‐Si EPID device mounted on the accelerator is positioned at 110 cm SDD and configured to operate in integrated image acquisition mode. Planar EPID images transverse to the beam direction are acquired for each treatment angle of an IMRT plan by direct irradiation of an a‐Si EPID. Using software developed in‐house these images are then transformed into fluence distributions for importation into a commercial treatment planning system. After import, the fluence distributions are then used to calculate dose distributions and compared with planned dose distributions. Results: Planar dose profile gamma analysis (3%, 3 mm) of two 6 MV prostate IMRT plans displays a 99% passing rate. Isocenter point of interest (POI) dose comparisons for 2 liver, 1 abdomen and 2 prostate treatment plans range between 2.8–4.2% Conclusions: IMRT dosimetric verification of planar dose profiles using an a‐Si EPID is feasible. POI dose comparisons indicate that our model might benefit by further refinements. Research sponsored by a grant from Oncology Data Systems, Inc, Oklahoma City, OK.

AB - Purpose: This study examines the feasibility of patient dosimetric verification of intensity modulated radiotherapy (IMRT) treatment plans using an amorphous silicon (a‐Si) electronic portal imaging device (EPID). Methods: Patient specific IMRT treatment plans are created and exported to a linear accelerator for dosimetric verification. An a‐Si EPID device mounted on the accelerator is positioned at 110 cm SDD and configured to operate in integrated image acquisition mode. Planar EPID images transverse to the beam direction are acquired for each treatment angle of an IMRT plan by direct irradiation of an a‐Si EPID. Using software developed in‐house these images are then transformed into fluence distributions for importation into a commercial treatment planning system. After import, the fluence distributions are then used to calculate dose distributions and compared with planned dose distributions. Results: Planar dose profile gamma analysis (3%, 3 mm) of two 6 MV prostate IMRT plans displays a 99% passing rate. Isocenter point of interest (POI) dose comparisons for 2 liver, 1 abdomen and 2 prostate treatment plans range between 2.8–4.2% Conclusions: IMRT dosimetric verification of planar dose profiles using an a‐Si EPID is feasible. POI dose comparisons indicate that our model might benefit by further refinements. Research sponsored by a grant from Oncology Data Systems, Inc, Oklahoma City, OK.

UR - http://www.scopus.com/inward/record.url?scp=85024819411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024819411&partnerID=8YFLogxK

U2 - 10.1118/1.3612017

DO - 10.1118/1.3612017

M3 - Article

VL - 38

SP - 3500

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -